These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21467668)

  • 21. Amorphous stabilization of BCS II drugs using mesoporous silica.
    Tu B; Jonnalagadda S
    Int J Pharm; 2024 Sep; 663():124555. PubMed ID: 39111354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
    Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation.
    Mishra A; Imam SS; Aqil M; Ahad A; Sultana Y; Ameeduzzafar ; Ali A
    Drug Deliv; 2016 May; 23(4):1486-94. PubMed ID: 26978072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy.
    Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
    Int J Pharm; 2011 May; 410(1-2):61-7. PubMed ID: 21421036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amorphous solid dispersions of carvedilol along with pH-modifiers improved pharmacokinetic properties under hypochlorhydoria.
    Halder S; Tabata A; Seto Y; Sato H; Onoue S
    Biopharm Drug Dispos; 2018 Apr; 39(4):232-242. PubMed ID: 29607517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of miscibility analysis and determination of Soluplus solubility map for development of carvedilol-loaded nanofibers.
    Kaljević O; Djuris J; Čalija B; Lavrič Z; Kristl J; Ibrić S
    Int J Pharm; 2017 Nov; 533(2):445-454. PubMed ID: 28495583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
    Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system.
    Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
    Chem Pharm Bull (Tokyo); 2011; 59(6):686-91. PubMed ID: 21628901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica.
    Vogt FG; Roberts-Skilton K; Kennedy-Gabb SA
    Pharm Res; 2013 Sep; 30(9):2315-31. PubMed ID: 23794037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasticized drug-loaded melt electrospun polymer mats: characterization, thermal degradation, and release kinetics.
    Balogh A; Drávavölgyi G; Faragó K; Farkas A; Vigh T; Sóti PL; Wagner I; Madarász J; Pataki H; Marosi G; Nagy ZK
    J Pharm Sci; 2014 Apr; 103(4):1278-87. PubMed ID: 24549788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide.
    Mura P; Valleri M; Fabianelli E; Maestrelli F; Cirri M
    Int J Pharm; 2019 May; 563():43-52. PubMed ID: 30926527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral hesperidin-Amorphization and improved dissolution properties by controlled loading onto porous silica.
    Wei Q; Keck CM; Müller RH
    Int J Pharm; 2017 Feb; 518(1-2):253-263. PubMed ID: 27871833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of processing methods on the dissolution of artemether from two non-ordered mesoporous silicas.
    Tahir H; Shahzad Y; Waters LJ; Hussain T; Yousaf AM; Mahmood T; Sheikh R
    Eur J Pharm Sci; 2018 Jan; 112():139-145. PubMed ID: 29166624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.